Salidroside attenuates myocardial ischemia-reperfusion injury via PI3K/Akt signaling pathway

Journal of Asian Natural Products Research

Volumn 15, Issue 3, 2013, Pages 244-252

  Xu, Mao Chun ^a   Shi, Hai Ming ^a   Gao, Xiu Fang ^a   Wang, Hao ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

apoptosis; myocardial ischemia reperfusion; salidroside; signal transduction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SALIDROSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RABBIT; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CHROMONES; GLUCOSIDES; MALE; MOLECULAR STRUCTURE; MORPHOLINES; MYOCYTES, CARDIAC; PHENOLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; REPERFUSION INJURY;

ORYCTOLAGUS CUNICULUS;

EID: 84878013083     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2012.762358     Document Type: Article

References (23)

1. K. Ueda, H. Takano, H. Hasegawa, Y. Niitsuma, Y.J. Qin, M. Ohtsuka, and I. Komuro, Arterioscl. Throm. Vas. 26, E108 (2006).
2. J. Vinten-Johansen, Z.Q. Zhao, A.J. Zatta, H. Kin, M.E. Halkos, and F. Kerendi, Basic Res. Cardiol. 100, 295 (2005).
3. D. Kanupriya, D. Prasad, M.S. Ram, R. Kumar, R.C. Sawhney, S.K. Sharma, G. Ilavazhagan, D. Kumar, and P.K. Banerjee, Mol. Cell. Biochem. 275, 1 (2005).
4. L. Zhang, H.X. Yu, Y. Sun, X.F. Lin, B. Chen, C. Tan, G.X. Cao, and Z.W. Wang, Eur. J. Pharmacol. 564, 18 (2007).
5. J.P. Zhang, A.H. Liu, R.R. Hou, J. Zhang, X. Jia, W.F. Jiang, and J.Z. Chen, Eur. J. Pharmacol. 607, 6 (2009).
6. Z.Q. Qu, Y. Zhou, Y.S. Zeng, Y.K. Lin, Y. Li, Z.Q. Zhong, and W.Y. Chan, Plos One. 7, 1 (2012).
7. H. Zhong, H. Xin, L.X. Wu, and Y.Z. Zhu, J. Pharmacol. Sci. 114, 399 (2010).
8. L.W. Sun, C.K. Isaak, Y.L. Zhou, J.C. Petkau, O. Karmin, Y.J. Liu, and Y.L. Siow, Life Sci. 91, 151 (2012).
9. L. Zhang, H.X. Yu, X.C. Zhao, X.F. Lin, C. Tan, G.X. Cao, and Z.W. Wang, Neurochem. Int. 57, 547 (2010).
10. L.N. Maslov, Y.B. Lishmanov, A.G. Arbuzov, A.V. Krylatov, E.V. Budankova, Y.N. Konkovskaya, V.N. Burkova, and E.A. Severova, Bull. Exp. Biol. Med. 147, 331 (2009).
11. H. Zhao, Y. Zhang, B. Liu, K. Meng, and C.Y. Wang, J. Med. Plants Res. 5, 6328 (2011).
12. Y. Fujio, T. Nguyen, D. Wencker, R.N. Kitsis, and K. Walsh, Circulation. 101, 660 (2000).
13. T. Matsui, L. Li, J.C. Wu, S.A. Cook, T. Nagoshi, M.H. Picard, R.L. Liao, and A. Rosenzweig, J. Biol. Chem. 277, 22896 (2002).
14. T. Uchiyama, R.M. Engelman, N. Maulik, and D.K. Das, Circulation. 109, 3042 (2004).
15. A. Tsang, D.J. Hausenloy, M.M. Mocanu, and D.M. Yellon, Circ. Res. 95, 230 (2004).
16. J. Raphael, S. Abedat, J. Rivo, K. Meir, R. Beeri, T. Pugatsch, Z.Y. Zuo, and Y. Gozal, J. Pharmacol. Exp. Ther. 318, 186 (2006).
17. H.A. Harrington, K.L. Ho, S. Ghosh, and K.C. Tung, Theor. Biol. Med. Model. 5, 1 (2008).
18. C. Tessier, A. Prigent-Tessier, S. Ferguson-Gottschall, Y. Gu, and G. Gibori, Endocrinology 142, 4086 (2001).
19. C. Tang, Y.H. Lu, J.H. Xie, F. Wang, J.N. Zou, J.S. Yang, Y.Y. Xing, and T. Xi, Anti-Cancer Drugs 20, 249 (2009).
20. L.G. Hu, Y.K. Sun, and J. Hu, Eur. J. Pharmacol. 628, 155 (2010).
21. S.I. Gharbi, M.J. Zvelebil, S.J. Shuttleworth, T. Hancox, N. Saghir, J.F. Timms, and M.D. Waterfield, Biochem. J. 404, 15 (2007).
22. W. Shen, H.M. Shi, W.H. Fan, X.P. Luo, B. Jin, and Y. Li, Mol. Biol. Rep. 38, 3821 (2011).
23. S. Minatoguchi, M. Arai, Y. Uno, T. Kariya, Y. Nishida, K. Hashimoto, M. Kawasaki, G. Takemura, T. Fujiwara, and J. Fujiwara, Br. J. Pharmacol. 128, 1667 (1999).